Short-term risk prediction model for pancreatic cancer in type 2 diabetes: development and validation across two independent Chinese cohorts
A new risk calculator helps identify which diabetic patients most need pancreatic cancer screening.
BACKGROUND: Individuals with diabetes are prioritised for pancreatic cancer screening. CONCLUSION: The STOP-DM model provides a practical approach to stratify pancreatic cancer risk and deliver targeted screening for individuals with type 2 diabetes, particularly those living with long-standing diabetes.
What the study was
- Study design
- Observational/Cohort Study
- Population
- BACKGROUND: Individuals with diabetes are prioritised for pancreatic cancer screening
- Sample size
- 330
- Category
- Early Detection
- Maturity
- Validated
- Journal
- Gut
Why it surfaced
Primary method is liquid biopsy/ctDNA/cfDNA for cancer detection; moderate relevance to watchlist
A plain-language summary of published research — not medical advice. Talk to a clinician about your own care.